KTZ-94580-89265 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-06
Dose 1 — Pfizer-BioNTech
2021-01-09
Registered in v-safe
2021-01-09
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea

Adult check-in
2021-01-10
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Fatigue or tiredness

Adult check-in
2021-01-11
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-12
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-13
Health check-in — day 7, dose 1
Feeling: Good · Joint pains

Adult check-in
2021-01-21
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-27
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-01-29
Dose 2 — Pfizer-BioNTech
2021-01-31
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-02-01
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-02-05
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-02-12
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-19
Survey response — day 21, dose 2
MedDRA: Cough, Respiratory symptom, Wheezing — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Upper respiratory symptoms, wheezing, cough

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-19
Report sent to call center — day 21, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-02-26
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-03-05
Survey response — day 35, dose 2
MedDRA: Cough, Nasal congestion — Feeling: Fair

Free text: Nasal congestion and cough.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-12
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-30
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-08-01
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-08-12
Call 1 — Left Voicemail
2022-01-29
Survey response — 12 months, dose 2
MedDRA: Benign hydatidiform mole, Nasopharyngitis — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Cold symptoms Molar pregnancy

MedDRA releases: 2024-11 · check-in free text available
2022-01-29
Report sent to call center — 12 months, dose 2
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-02-01
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-06	Pfizer-BioNTech
2	2021-01-29	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-02-19	Unsuccessful
2022-01-29	Unsuccessful

Free text

Release 4 — day 21, dose 2

2021-02-19

Symptoms: Upper respiratory symptoms, wheezing, cough

Release 5 — day 35, dose 2

2021-03-05

Symptoms: Nasal congestion and cough.

Release 11 — 12 months, dose 2

2022-01-29

Symptoms: Cold symptoms Molar pregnancy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Benign hydatidiform mole	·	·	✓
SD	Cough	✓	✓	✓
SD	Nasal congestion	✓	✓	✓
SD	Nasopharyngitis	·	·	✓
SD	Respiratory symptom	✓	✓	✓
SD	Wheezing	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release